Target intelligence / Profile preview

novel transcript, antisense to NBPF20

Molecular classification
Other (long non-coding RNA; lncRNA)
01

Overview

"novel transcript, antisense to NBPF20" (ENSG00000303361) refers to a long non-coding RNA gene annotated in the human genome that is antisense to the NBPF20 protein-coding gene. It does not encode a protein and is not described in major functional, disease, or drug-target databases. There is insufficient published evidence to support any role as a therapeutic target, biomarker, or disease-gene. It is likely an annotation for a putative lncRNA, detected by computational transcriptome analysis rather than experimental validation[3]. The actual NBPF20 gene (NBPF member 20) is a protein-coding gene, unrelated to this antisense lncRNA, and is found as ENSG00000162825[1][2][5][6][7][8]. Therefore, if you intended an actual target for therapeutic or drug discovery purposes, ENSG00000303361 is not appropriate, and the correct entry would be NBPF20 (ENSG00000162825)[1][2][5][8].

Other names
novel transcript, antisense to NBPF20ENSG00000303361

Beyond the preview

Go deeper on novel transcript, antisense to NBPF20.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to NBPF20.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call